Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2010
12/15/2010EP2260852A2 Bisphosphonate conjugates and methods of making and using the same
12/15/2010EP1539818B1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
12/15/2010CN101918443A Antigen associated with rheumatoid arthritis
12/15/2010CN101918042A Stabilization of radiopharmaceuticals
12/15/2010CN101918041A Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
12/15/2010CN101918040A Method of differentially diagnosing different types of dementia
12/15/2010CN101918039A Use of novel compound having affinity for amyloid, and process for production of the same
12/15/2010CN101913973A Preparation and use of alkylating agents
12/14/2010US7851496 Ionic liquid type crown ether derivatives, method for preparing the same and method for isolating metal ions using the same
12/14/2010US7851444 χ-conotoxin peptides (-1)
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850962 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
12/14/2010US7850948 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
12/14/2010US7850947 Gastrin releasing peptide compounds
12/14/2010US7850946 intramolecular linked drug/biological conjugates, that absorb and emit light in the near infrared region of electromagnetic spectrum, having improved stability, high receptor binding affinity and pharmacokinetics, useful as imaging or contrast agents
12/09/2010WO2010141566A1 Conjugation methods
12/09/2010WO2010139075A1 Synthesis and use of radiolabelled insulin analogues
12/09/2010WO2010028817A3 Labelled adiponectin derivatives
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100310506 Immunoconjugates for the Treatment of Tumours
12/09/2010US20100310457 Imaging of myelin basic protein
12/09/2010US20100310456 Imaging of myelin basic protein
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010US20100310454 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpart
12/09/2010US20100310453 Heterologous antibodies which bind human cd4
12/09/2010US20100310452 Prostate-specific membrane antigen and uses thereof
12/09/2010US20100310451 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
12/09/2010US20100310450 method of diagnosis and agents useful for same
12/09/2010CA2763749A1 Synthesis and use of radiolabelled insulin analogues
12/09/2010CA2761959A1 Conjugation methods
12/08/2010EP2258403A1 Radiolabelled conjugates of RGD-containing peptides and methods for their preparation via click-chemistry
12/08/2010EP2258401A2 Folate-receptor targeted imaging agents
12/08/2010EP2257315A2 Contrast agents for applications including perfusion imaging
12/08/2010EP2257314A2 Peptide targeting imaging agents and methods of use thereof
12/08/2010EP2257309A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010CN1995020B Radioactive iodine-17- allylamino-17-demethoxygeldanamycin and its preparation method
12/08/2010CN101909659A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101909658A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101909657A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101905028A Method for preparing iodine [1251] sealed seed source core
12/08/2010CN101337080B Radionuclide particle implantation medicine for cancer, use and preparation method thereof
12/08/2010CN101198360B A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
12/08/2010CN101028525B Use of tumor caryon single-antibody in physical therapeutic tumor as synergist
12/07/2010US7846419 generating radioactive isotopes for positron emission tomography by the acceleration of a projectile in a linear accelerator that is operative to accelerate at least two different types of projectiles and generate at least two different corresponding types of radioactive isotopes
12/07/2010CA2573201C Injection of a radioactive dye for sentinel lymph node identification
12/07/2010CA2468777C Methods and apparatus for producing 15o-carbon monoxide and 15o-carbon dioxide
12/07/2010CA2375968C Imaging the dopamine transporter to determine ad-hd
12/07/2010CA2352094C High energy phototherapeutic agents
12/07/2010CA2326720C Hemoglobin-haptoglobin complexes
12/07/2010CA2285516C Dopamine transporter imaging agents
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010118706A3 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
12/02/2010WO2010065899A3 Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof
12/02/2010WO2010013136A3 Active particles for bio-analytical applications and methods for their preparation
12/02/2010US20100303720 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
12/02/2010US20100303719 Anti-cancer compounds
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010US20100303716 Switchable nano-vehicle delivery systems, and methods for making and using them
12/02/2010US20100303715 Prostate-specific membrane antigen and uses thereof
12/02/2010US20100303714 Oncolytic vaccinia virus cancer therapy
12/02/2010CA2763130A1 Radiolabeled pde10 inhibitors
12/01/2010EP2254604A2 Polyether polyol dendron conjugates with effector molecules for biological targeting
12/01/2010EP1137441B1 Ion exchange tumor targeting (iett)
12/01/2010CN1723042B Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
12/01/2010CN101903047A Selective radiolabeling of biomolecules
12/01/2010CN101417135B Preparation method of biodegradable fallout radioactive material for treating cancer
12/01/2010CN101289466B <99>Tc<m>N nucleus marked ciprofloxacin dithiocarbamate complexes, preparation and applications
11/2010
11/30/2010US7842279 reacting a peptide comprising a hydroxylamine, a thiosemicarbazide, a hydrazine or a free amine group with a complex of sodium bisulfite and radioactive 4-[18F]Fluorobenzaldehyde to form C-N double bond betweein neucleophillic nitrogen and 18F]Fluorobenzaldehyde; clinical positron emission tomography
11/30/2010US7842278 also anticarcinogenic, antiinflammatory, antiischemic agent; contains a boron cluster for boron neutron capture therapy (BNCT) or positron emitting radionuclide for non-invasive positron emission tomography (PET) and magnetic resonance imaging (MRI) with other therapeutic agent
11/30/2010CA2384879C Nitroimidazole derivative and diagnostic imaging agent containing the same
11/25/2010WO2010135180A1 Catalysis of fluorine addition to double bonds
11/25/2010WO2010109007A3 Tricyclic indole derivates as pbr ligands
11/25/2010US20100297007 Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
11/25/2010US20100297005 Nucleic acids and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
11/25/2010US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/24/2010EP2253333A2 Contrast Agents for Myocardial Perfusion Imaging
11/24/2010EP2252628A1 Bombesin analog peptide antagonist conjugates
11/24/2010EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
11/24/2010CN1929869B Phospholipid analogs as diagnostic and therapeutic agents for numerous cancers
11/24/2010CN101891791A Derivate for labeling bile acid and reference compound, preparation method and application thereof
11/24/2010CN101891687A Method for synthesizing hypoxia imaging agent 18F-FMISO
11/24/2010CN101890297A Method for condensing and purifying radioactive nuclide gallium-68
11/24/2010CN101219226B Medicinal box of GSA for producing technetium-99m mark and method for producing the same
11/24/2010CN101182333B 99mTc marked 2-methoxyphenyl piperazine derivative complexes as well as preparation method and uses thereof
11/23/2010US7837995 Anticancer agents; low dosage; side effect reduction
11/23/2010US7837982 Imaging agents
11/23/2010US7837981 Methods for imaging soluble A-beta
11/23/2010US7837980 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group
11/18/2010WO2010132428A1 Fluorescent phospholipid ether compounds, compositions, and methods of use
11/18/2010WO2010131745A1 18f-labeled azide compound, reagent for 18f-labeling and method for 18f-labeling of alkyne compound using same
11/18/2010WO2010131590A1 Diagnostic agent and therapeutic agent for tumors
11/18/2010WO2010007329A3 Novel method for measuring insulin resistance
11/18/2010WO2009141079A8 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/18/2010US20100292441 Antibodies that specifically bind to GMAD
11/18/2010US20100290991 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation
11/18/2010US20100290990 Method for preparing a marked purine derivative, said derivative and uses thereof
11/18/2010US20100290989 Compositions affecting hyaluronic acid mediated activity
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 243